TABLE 2.
Preoperative | Postoperative | P | |
---|---|---|---|
Age (yr) | 43 ± 9 | NA | |
Females/males | 12/8 | NA | |
Time between biopsies (mo) | 15 ± 7 | NA | |
BMI (kg/m2) | 54 ± 9 | 36 ± 9 | <0.001 |
Fasting glucose (mg/dL) | 126 ± 34 | 97 ± 24 | 0.001 |
AST (IU/L) | 30 ± 13 | 24 ± 9 | 0.059 |
ALT (IU/L) | 43 ± 20 | 34 ± 12 | 0.044 |
Lipids* | |||
Total cholesterol (mg/dL) | 206 ± 52 | 178 ± 49 | 0.02 |
Triglycerides (mg/dL) | 195 ± 92 | 117 ± 68 | <0.001 |
HDL cholesterol (mg/dL) | 41 ± 14 | 44 ± 14 | 0.183 |
LDL cholesterol (mg/dL) | 130 ± 39 | 116 ± 40 | 0.078 |
Metabolic syndrome (%) | 12 (60) | 0 (0) | 0.001 |
Hypertension (%) | 12 (60) | 2 (10) | 0.002 |
Diabetes mellitus (%) | 7 (35) | 1 (5) | 0.014 |
Insulin use (%) | 2 (10) | 1 (5) | 0.317 |
Dyslipidemia (%) | 18 (90) | 5 (25) | <0.001 |
Liver histology scores | |||
Steatosis | 2.6 ± 0.7 | 0.7 ± 0.8 | <0.001 |
Inflammation | 1.7 ± 0.7 | 0.9 ± 0.5 | 0.001 |
Fibrosis | 1.6 ± 1.0 | 1.3 ± 1.0 | 0.035 |
Disease grade | 2.2 ± 0.7 | 0.9 ± 0.4 | <0.001 |
Disease stage | 1.7 ± 1.0 | 1.3 ± 1.0 | 0.011 |
Values are expressed as mean ± SD or n (%).
Excludes 2 patients missing postoperative lipid measures (n = 18).